Thus, until these challenges are addressed, shRNA/siRNA screens are most productive with carefully designed synthetic lethal or synthetic sick phenotype as has been done around the Myc proto-oncogene frequently amplified in many cancers (Cermelli et al. 2014; Kessler et al. 2012; Toyoshima et al. 2012). This evidence concerns the gene MYC and cancer.